[go: up one dir, main page]

PE20090629A1 - Pirazinas y piperidinas piperazinil sustituidas como antagonistas del receptor 5-ht7 - Google Patents

Pirazinas y piperidinas piperazinil sustituidas como antagonistas del receptor 5-ht7

Info

Publication number
PE20090629A1
PE20090629A1 PE2008001449A PE2008001449A PE20090629A1 PE 20090629 A1 PE20090629 A1 PE 20090629A1 PE 2008001449 A PE2008001449 A PE 2008001449A PE 2008001449 A PE2008001449 A PE 2008001449A PE 20090629 A1 PE20090629 A1 PE 20090629A1
Authority
PE
Peru
Prior art keywords
methyl
ethyl
phenyl
receptor
bencensulfonamide
Prior art date
Application number
PE2008001449A
Other languages
English (en)
Inventor
Sean Patrick Hollinshead
Sandra Ann Filla
Michael Wade Tidwell
Sarah Lynne Hellman
Michael Philip Cohen
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PE20090629A1 publication Critical patent/PE20090629A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/20Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

SE REFIERE A COMPUESTOS DERIVADOS DE PIRAZINAS Y PIPERIDINAS PIPERAZINIL DE FORMULA (I) DONDE A ES -C(H)= O -N=; R1 ES FENILO OPCIONALMENTE SUSTITUIDO CON FLUOR O CLORO, PIRAZOL-4-ILO OPCIONALMENTE SUSTITUIDO CON METILO O ETILO, IMIDAZOLILO, ENTRE OTROS; R2 ES H O METILO; m ES DE 0 A 2; R3 ES H, FLUOR, HIDROXI, METOXI, ENTRE OTROS; R4 ES FLUOR, CLORO, METILO, METOXI, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: CLORHIDRATO DE N-{2-[3'-(4-METOXIMETIL-FENIL)-2,3,5,6-TETRAHIDRO-[1,2']BIPIRAZINIL-4-IL]-ETIL}-N-METIL-BENCENSULFONAMIDA, CLORHIDRATO DE 4-FLUORO-N-{2-[3'-(4-METOXIMETIL-FENIL)-2,3,5,6-TETRAHIDRO-[1,2']BIPIRAZINIL-4-IL]-ETIL}-N-METIL-BENCENSULFONAMIDA, CLORHIDRATO DE N-{2-[3'-(4-FLUORO-FENIL)-2,3,5,6-TETRAHIDRO-[1,2']BIPIRAZINIL-4-IL]-ETIL}-4-METOXI-N-METIL-BENCENSULFONAMIDA, ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON ANTAGONISTAS SELECTIVOS DEL RECEPTOR 5-TH7 SIENDO UTILES EN EL TRATAMIENTO DE MIGRANA
PE2008001449A 2007-08-28 2008-08-27 Pirazinas y piperidinas piperazinil sustituidas como antagonistas del receptor 5-ht7 PE20090629A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96834407P 2007-08-28 2007-08-28
US4875208P 2008-04-29 2008-04-29

Publications (1)

Publication Number Publication Date
PE20090629A1 true PE20090629A1 (es) 2009-05-16

Family

ID=39873874

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008001449A PE20090629A1 (es) 2007-08-28 2008-08-27 Pirazinas y piperidinas piperazinil sustituidas como antagonistas del receptor 5-ht7

Country Status (21)

Country Link
US (1) US8048884B2 (es)
EP (1) EP2188268B1 (es)
JP (1) JP5290293B2 (es)
KR (1) KR101148616B1 (es)
CN (1) CN101790522B (es)
AR (1) AR068111A1 (es)
AT (1) ATE520673T1 (es)
AU (1) AU2008293715B2 (es)
BR (1) BRPI0816468A2 (es)
CA (1) CA2694911C (es)
CY (1) CY1111848T1 (es)
DK (1) DK2188268T3 (es)
EA (1) EA017809B1 (es)
HR (1) HRP20110624T1 (es)
MX (1) MX2010002352A (es)
PE (1) PE20090629A1 (es)
PL (1) PL2188268T3 (es)
PT (1) PT2188268E (es)
SI (1) SI2188268T1 (es)
TW (1) TW200914020A (es)
WO (1) WO2009029439A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI118473B (fi) 2006-02-17 2007-11-30 Outotec Oyj Menetelmä kuparin talteenottamiseksi kuparisulfidimalmista
US7910588B2 (en) * 2007-10-12 2011-03-22 Eli Lilly And Company 5-HT7 receptor antagonists
EP2558458B1 (de) 2010-04-16 2017-09-06 Bayer Intellectual Property GmbH Neue heterocyclische verbindungen als schädlingsbekämpfungsmittel
AU2012323038B2 (en) 2011-10-11 2016-09-08 Ucb Pharma, S.A. 2-oxo-piperidinyl derivatives
FR2995605B1 (fr) 2012-09-18 2014-09-19 Sanofi Sa Derives de macrolides, leur preparation et leur application therapeutique.
CA2932051A1 (en) 2013-12-20 2015-06-25 Laboratorios Del Dr. Esteve, S.A. Piperazine derivatives having multimodal activity against pain
CN110475773B (zh) 2017-03-03 2025-06-24 琳达·佳慧·余 8-苯基异喹啉及其医药组合物用于治疗肠易激综合征
KR102014335B1 (ko) * 2017-12-01 2019-08-26 한국과학기술연구원 5-ht7 수용체의 조절제로 작용하는 아릴피라졸릴피페라진 또는 아릴피라졸릴다이아제페인의 유도체 및 이를 포함하는 중추신경계 질환 치료 또는 예방용 약학 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1149195C (zh) * 1999-02-10 2004-05-12 伊莱利利公司 5-ht1f激动剂
US20030008880A1 (en) * 2001-05-02 2003-01-09 Pfizer Inc. 4-(2-Pyridyl) piperizines having 5HT7 receptor agonist activity
US7153858B2 (en) * 2003-01-31 2006-12-26 Epix Delaware, Inc. Arylpiperazinyl compounds
CA2514656A1 (en) * 2003-01-31 2004-08-12 Pfizer Products Inc. 5ht7 antagonists and inverse agonists

Also Published As

Publication number Publication date
AU2008293715A1 (en) 2009-03-05
TW200914020A (en) 2009-04-01
CN101790522A (zh) 2010-07-28
CN101790522B (zh) 2012-06-27
US8048884B2 (en) 2011-11-01
KR101148616B1 (ko) 2012-05-21
EP2188268B1 (en) 2011-08-17
CA2694911A1 (en) 2009-03-05
CA2694911C (en) 2013-05-07
BRPI0816468A2 (pt) 2015-03-24
HRP20110624T1 (hr) 2011-09-30
PL2188268T3 (pl) 2011-12-30
DK2188268T3 (da) 2011-10-03
US20100075976A1 (en) 2010-03-25
JP5290293B2 (ja) 2013-09-18
MX2010002352A (es) 2010-08-04
EA201070321A1 (ru) 2010-08-30
PT2188268E (pt) 2011-10-03
CY1111848T1 (el) 2015-10-07
EP2188268A1 (en) 2010-05-26
JP2010537994A (ja) 2010-12-09
EA017809B1 (ru) 2013-03-29
ATE520673T1 (de) 2011-09-15
SI2188268T1 (sl) 2011-11-30
AU2008293715B2 (en) 2013-09-19
AR068111A1 (es) 2009-11-04
KR20100038117A (ko) 2010-04-12
WO2009029439A1 (en) 2009-03-05

Similar Documents

Publication Publication Date Title
PE20090629A1 (es) Pirazinas y piperidinas piperazinil sustituidas como antagonistas del receptor 5-ht7
NO20063599L (no) Ytterligere heterosykliske forbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister
DE602005014086D1 (de) Pyrimidinderivate als orexin-rezeptorantagonisten
PE20090237A1 (es) Derivados de sulfonamidas como inhibidores de los canales de sodio
PE20091734A1 (es) Compuestos de 2-imino-3-metilpirrolopirimidinona fenilo-sustituida como inhibidores de bace-1, composiciones y su uso
EA200901379A1 (ru) Производные никотиновой кислоты как модуляторы метаботропных глутаматных рецепторов 5 подтипа
NO20074287L (no) Pyrazin-2-karboksamidderivater som mGluR5 antagonister
NO20072435L (no) CGRP-reseptorantagonister
PE20121050A1 (es) Compuestos de n-(1-(4-(1h-pirazol-5-il)ftalazin-1-il)piperidin-4-il)-benzamida sustituidos como antagonistas de la trayectoria hedgehog
PE20061366A1 (es) Compuestos y composiciones como inhibidores de quinasa de proteina
PE20061436A1 (es) Derivados de amida sustituida como inhibidores de proteina quinasa
PE20090895A1 (es) Derivados de triazol como inhibidores de la jak quinasa
ECSP045367A (es) "derivados de bencimidazol utiles como antagonistas de histamina h3"
HRP20070076A2 (en) Pyrimidine derivatives
CY1112019T1 (el) Αγωνιστες υποδοχεων νιασινης, συνθεσεις που περιεχουν τετοιες ενωσεις και μεθοδοι θεραπειας
PE20060736A1 (es) DERIVADOS DE PIRROL COMO ANTAGONISTAS DE CRTh2
ATE537170T1 (de) Cgrp-rezeptorantagonisten
NO20091052L (no) Diaryleterderivater og anvendelser derav
ATE418548T1 (de) Substituierte 3-cyanothiophen acetamide als glucagon receptor antagonisten
NO20060195L (no) Kinolylamidderivater som CCR-5-antagonister
PE20081665A1 (es) Antagonistas del receptor de dopamina 2 de rapida disociacion
ATE503755T1 (de) Cgrp-rezeptorantagonisten
DE602004005960D1 (de) Heteroaryl-substituierte pyrrolä2, 3- büpyridin-derivate als crf-rezeptor-antagonisten
WO2006100081A3 (de) Substituierte oxindol-derivate, diese enthaltende arzneimittel und deren verwendung
ATE478856T1 (de) Spirobenzodioxole und deren verwendung als cb1- antagonisten

Legal Events

Date Code Title Description
FD Application declared void or lapsed